2-Year U.S. Treasury Note Continuous Contract $101.367 0.039 0.04% 5-Year U.S. Treasury Note Continuous Contract $104.859 0.117 0.11% 10-Year U.S. Treasury Note Continuous Contract $107.641 0.203 ...
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like ...